Form 4: AMWL Chief Accounting Officer Sells Shares for Tax
Insider Transaction Report
American Well Corp's Chief Accounting Officer, Paul McNeice, sold 130 shares of Class A Common Stock to cover tax liabilities from restricted stock unit vesting.
Summary
- Paul Francis McNeice, Chief Accounting Officer of American Well Corp (AMWL), reported a transaction involving the company's Class A Common Stock.
- On March 2, 2026, McNeice sold 130 shares of Class A Common Stock at a price of $5.24 per share.
- The sale was an automatic "sell to cover" transaction, executed to satisfy tax liabilities that arose from the vesting and settlement of restricted stock units on March 1, 2026.
- This transaction was not a discretionary trade by the reporting person.
- Following this sale, McNeice directly beneficially owns 2,933 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it's a non-discretionary sale for tax purposes, which is a common occurrence for executives receiving equity compensation and does not reflect a change in management's outlook.
Positives
- The sale was not a discretionary trade by the Chief Accounting Officer, but rather an automatic "sell to cover" transaction for tax purposes, indicating a routine event rather than a change in sentiment.
Negatives
- Chief Accounting Officer Paul McNeice reduced his direct beneficial ownership by 130 shares of Class A Common Stock.
Future Outlook
NA
Management Comments
- "The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on March 1, 2026."
- "The sales were effected through an automatic 'sell to cover' transaction that did not represent a discretionary trade by the reporting person."
Industry Context
StockSavvy.ai notes that 'sell to cover' transactions are a common and routine practice for executives receiving equity compensation, such as restricted stock units, to manage tax obligations upon vesting. These transactions are generally not indicative of management's discretionary view on the company's future performance or stock price.
Comparison to Industry Standards
- This 'sell to cover' transaction is a common practice among executives in publicly traded companies across various industries, including healthcare technology, when equity awards vest, to manage tax obligations without requiring personal funds. It aligns with standard compensation and tax management practices seen at companies like Teladoc Health (TDOC) or Livongo Health (acquired by TDOC), where executives routinely sell shares to cover taxes on vested equity.
Stakeholder Impact
- Shareholders: A very minor increase in the public float due to the sale of shares, though the primary impact stems from the underlying RSU vesting rather than the sale itself.
Key Dates
| Date | Description |
|---|---|
| 03/01/2026 | Vesting and settlement of restricted stock units. |
| 03/02/2026 | Transaction date for the sale of Class A Common Stock. |
| 03/03/2026 | Signature date of the Form 4 filing. |
Recommendation
holdThis Form 4 reports a routine "sell to cover" transaction by a Chief Accounting Officer to satisfy tax obligations upon RSU vesting. It is not a discretionary sale and therefore does not signal a change in management's confidence or the company's fundamentals. As such, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation.
Keywords
American Well Corp, AMWL, Form 4, insider transaction, stock sale, Chief Accounting Officer, Paul McNeice, restricted stock units, RSU, sell to cover
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.